Gulf Scientific Corporation (GSC) Partners with SOPHiA GENETICS to Advance Precision Medicine in the GCC

$800M Agreement Signed to Localize Gene and Targeted Cell Therapy in Saudi Arabia

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as First-Line Treatment for Advanced G/GEJ Cancer and ESCC

FDA Approves Thermo Fisher’s Oncomine™ Dx Target Test as CDx for VORANIGO® to Treat IDH-Mutant Gliomas

Chang Gung Memorial Hospital Pioneers Cellular Therapy Innovations in Cancer Treatment

4baseCare Launches New Office and Genomics Lab in Dubai Science Park

CHMP Recommends AstraZeneca and Ionis' Wainzua for EU Approval to Treat ATTRv-PN

Astellas Announces FDA Approval of VYLOY™ (Zolbetuximab) as First CLDN18.2-Targeted Therapy for Advanced Gastric and GEJ Cancers

ANGLE plc Publishes Study Demonstrating Parsortix® System’s Role in Prostate Cancer Biomarker Detection and Therapy Development

Pathkind Diagnostics and Sebia Partner to Transform Autoimmune Disease Diagnostics in India

Yourgene Health Receives IVDR Accreditation for Cystic Fibrosis Base Assay

GE HealthCare and University Medicine Essen Partner to Establish Theranostics Centre in Germany

Sanofi and Orano Collaborate to Advance Next-Generation Radioligand Therapies

MedGenome Celebrates a Decade of Genomics Innovation

PathPresenter and Paige Partner to Drive Adoption of AI-Powered Digital Pathology and Image Management Workflows